HARLOW, England, September 30, 2014 /PRNewswire/ --
Diamond BioPharm Ltd announce today the opening of a new satellite office at Cambridge Science Park. As part of a phase of expansion, Diamond will locate product development and regulatory consultants in Cambridge whilst maintaining a head office in Harlow. The Cambridge team have a proven track record in supporting biotechnology and pharmaceutical companies at the frontiers of therapeutic research and development. Diamond have provided key support to companies developing products in the areas of new-chemical-entities, biologics and advanced therapies, including gene and cell therapies. Notable successes include assisting in the successful market approval of the first gene therapy in Europe.
"We are delighted to be expanding into our new satellite office in Cambridge," said Dr Maureen Graham, Managing Director of Diamond BioPharm Ltd. "This move will allow us to continue to deliver an outstanding consulting service to our clients through all stages of product development, and to provide support and leadership during interactions with regulatory agencies."
About Diamond BioPharm Ltd
Diamond BioPharm Ltd was founded in 2005 by Dr Maureen Graham. The company is part of the Diamond Pharma Services group of companies, a leading technical and scientific consulting group serving the biotechnology and pharmaceutical industry, with an emphasis on:
Regulatory Affairs: from product concept to registration and beyond
Product Development: Chemistry manufacturing and control (CMC), non-clinical and clinical
Pharmacovigilance: Clinical trial (phase I-IV), post marketing and QPPV services
Compliance: GLP, GMP, GCP and QP services
Please visit the Diamond Pharma Services website http://www.diamondpharmaservices.com or contact us on +44(0)845-070-4336
SOURCE Diamond BioPharm Ltd.